A00056
antibody from Boster Biological Technology
Targeting: CCL2
GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- A00056 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-C-C motif chemokine 2 CCL2 Antibody
- Antibody type
- Polyclonal
- Description
- Anti-C-C motif chemokine 2 CCL2 Antibody validated for ELISA, WB, IHC, IF. Reactive to Human, Mouse, Rat.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1 mg/mL
- Storage
- At -20°C for one year. At 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
Submitted references Host liver-derived extracellular vesicles deliver miR-142a-3p induces neutrophil extracellular traps via targeting WASL to block the development of Schistosoma japonicum.
Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients.
CCL2-CCR2 Axis Potentiates NMDA Receptor Signaling to Aggravate Neuropathic Pain Induced by Brachial Plexus Avulsion.
Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.
Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia.
Wang L, Zhu Z, Liao Y, Zhang L, Yu Z, Yang R, Wu J, Wu Z, Sun X
Molecular therapy : the journal of the American Society of Gene Therapy 2022 May 4;30(5):2092-2107
Molecular therapy : the journal of the American Society of Gene Therapy 2022 May 4;30(5):2092-2107
Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients.
Zhang L, Xie F, Tang H, Zhang X, Hu J, Zhong X, Gong N, Lai Y, Zhou M, Tian J, Zhou Z, Xie L, Hu Z, Zhu F, Jiang J, Nie J
Translational research : the journal of laboratory and clinical medicine 2022 Feb;240:50-63
Translational research : the journal of laboratory and clinical medicine 2022 Feb;240:50-63
CCL2-CCR2 Axis Potentiates NMDA Receptor Signaling to Aggravate Neuropathic Pain Induced by Brachial Plexus Avulsion.
Xian H, Jiang Y, Zhang H, Ma SB, Zhao R, Cong R
Neuroscience 2020 Jan 15;425:29-38
Neuroscience 2020 Jan 15;425:29-38
Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.
Xu HL, Wang XT, Cheng Y, Zhao JG, Zhou YJ, Yang JJ, Qi MY
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Sep;105:915-921
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Sep;105:915-921
Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia.
Ma Y, Kong LR, Ge Q, Lu YY, Hong MN, Zhang Y, Ruan CC, Gao PJ
Journal of cellular and molecular medicine 2018 Feb;22(2):1034-1046
Journal of cellular and molecular medicine 2018 Feb;22(2):1034-1046
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image
- Experimental details
- Western blot analysis of CCL2 in K562 cell lysate with CCL2 antibody at 1 μg/mL.
- Additional image